Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Wagner

Showing results (291-300 of 303) with videos related to

Pageof 31
Sort By:
Cardiology Journal|April 28, 2026
Quantitative imaging in cardiac transthyretin amyloidosis: rationale and design of the i-CARE studyHendrea S A Tingen, Craig Balmforth, Neil Craig, et al.
ERJ Open Research|April 1, 2026
Access to lymphangioleiomyomatosis care across Europe: an ERN-LUNG survey of clinical practice, and the case for a European registry and trial networkDonal O'Malley, Elisabeth Humbert-Dorfmüller, Joan A Barberà, et al.
American Journal of Respiratory and Critical Care Medicine|May 2, 2013
Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trialMatthias Griese, Matthias Kappler, Claudia Eismann, et al.
Melanoma Research|July 1, 2021
Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanomaAlexandra M Adams, Robert C Chick, Timothy J Vreeland, et al.
Cancer Medicine|May 13, 2021
Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysisRobert C Chick, Mark B Faries, Diane F Hale, et al.
The Science of the Total Environment|August 28, 2024
Factors controlling the water quality of rock glacier springs in European and American mountain rangesStefano Brighenti, Nicola Colombo, Thomas Wagner, et al.
The Science of the Total Environment|March 26, 2025
Validation of GEMS operational v2.0 total column NO<sub>2</sub> and HCHO during the GMAP/SIJAQ campaignKangho Bae, Chang-Keun Song, Michel Van Roozendael, et al.
Orphanet Journal of Rare Diseases|April 14, 2026
European Reference Networks - a flagship activity of the EU in the field of rare and complex diseases: from 2017 to 2025Holm Graessner, Sophie Ripp, Alberto M Pereira, et al.
Frontiers in Pediatrics|November 15, 2021
Results of WICOVIR Gargle Pool PCR Testing in German Schools Based on the First 100,000 TestsParastoo Kheiroddin, Patricia Schöberl, Michael Althammer, et al.
Cancer Treatment and Research Communications|September 21, 2024
Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trialSpencer G Van Decar, Elizabeth L Carpenter, Alexandra M Adams, et al.
Pageof 31

Showing results (291-300 of 303) with videos related to

Sort By:
Pageof 31
Cardiology Journal|April 28, 2026
Quantitative imaging in cardiac transthyretin amyloidosis: rationale and design of the i-CARE studyHendrea S A Tingen, Craig Balmforth, Neil Craig, et al.
ERJ Open Research|April 1, 2026
Access to lymphangioleiomyomatosis care across Europe: an ERN-LUNG survey of clinical practice, and the case for a European registry and trial networkDonal O'Malley, Elisabeth Humbert-Dorfmüller, Joan A Barberà, et al.
American Journal of Respiratory and Critical Care Medicine|May 2, 2013
Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trialMatthias Griese, Matthias Kappler, Claudia Eismann, et al.
Melanoma Research|July 1, 2021
Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanomaAlexandra M Adams, Robert C Chick, Timothy J Vreeland, et al.
Cancer Medicine|May 13, 2021
Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysisRobert C Chick, Mark B Faries, Diane F Hale, et al.
The Science of the Total Environment|August 28, 2024
Factors controlling the water quality of rock glacier springs in European and American mountain rangesStefano Brighenti, Nicola Colombo, Thomas Wagner, et al.
The Science of the Total Environment|March 26, 2025
Validation of GEMS operational v2.0 total column NO<sub>2</sub> and HCHO during the GMAP/SIJAQ campaignKangho Bae, Chang-Keun Song, Michel Van Roozendael, et al.
Orphanet Journal of Rare Diseases|April 14, 2026
European Reference Networks - a flagship activity of the EU in the field of rare and complex diseases: from 2017 to 2025Holm Graessner, Sophie Ripp, Alberto M Pereira, et al.
Frontiers in Pediatrics|November 15, 2021
Results of WICOVIR Gargle Pool PCR Testing in German Schools Based on the First 100,000 TestsParastoo Kheiroddin, Patricia Schöberl, Michael Althammer, et al.
Cancer Treatment and Research Communications|September 21, 2024
Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trialSpencer G Van Decar, Elizabeth L Carpenter, Alexandra M Adams, et al.
Pageof 31